74 144

Cited 8 times in

A genetic variant in GLP1R is associated with response to DPP-4 inhibitors in patients with type 2 diabetes

Authors
 Eugene Han  ;  Hye Sun Park  ;  Obin Kwon  ;  Eun Yeong Choe  ;  Hye Jin Wang  ;  Yong-ho Lee  ;  Sang-Hak Lee  ;  Chul Hoon Kim  ;  Lee-Kyung Kim  ;  Soo Heon Kwak  ;  Kyong Soo Park  ;  Chul Sik Kim  ;  Eun Seok Kang 
Citation
 Medicine, Vol.95(44) : 5155-5155, 2016 
Journal Title
 Medicine 
ISSN
 0025-7974 
Issue Date
2016
Abstract
Incretin hormone-based therapy in type 2 diabetes has been widely used, and dipepdityl peptidase-4 (DPP-4) inhibitors, which prevent incretin degradation, have become popular oral hypoglycemic agents. The efficacy of DPP-4 inhibitors varies from individuals, and factors determining responses to DPP-4 inhibitors have not been fully established. We aimed to investigate whether genetic variations in glucagon-like peptide (GLP-1) receptor are associated with responses to DPP-4 inhibitors in patients with type 2 diabetes.Genetic variations of rs3765467 in GLP-1 receptor were explored in 246 patients with type 2 diabetes who received DPP-4 inhibitors treatment for 24 weeks in addition to previous medication. Patients with glycated hemoglobin (HbA1c) > 7% and who were naive to any DPP-4 inhibitors were enrolled. Responders were defined as those who showed a > 10% reduction in HbA1c after DPP-4 inhibitor treatment.DPP-4 inhibitors improved glycemic parameters and lipid profiles. Compared to the major genotype (GG), a larger proportion of patients with the minor allele genotype (GA/AA) were responders (P?=?0.018), and also showing greater HbA1c reductions (1.3?±?1.1 vs 0.9?±?1.2%; P?=?0.022). This genetic effect remained significant even after adjustment for other confounding factors (OR?=?2.00, 95% CI?=?1.03-3.89).Polymorphism in the GLP-1 receptor may influence DPP-4 inhibitor response. Further studies in larger population will help determine the association between genetic variation and interindividual differences in DPP-4 inhibitor therapy.
Files in This Item:
T201604763.pdf Download
DOI
10.1097/MD.0000000000005155
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Pharmacology (약리학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Yonsei Biomedical Research Center (연세의생명연구원) > 1. Journal Papers
Yonsei Authors
강은석(Kang, Eun Seok) ORCID logo https://orcid.org/0000-0002-0364-4675
김철훈(Kim, Chul Hoon) ORCID logo https://orcid.org/0000-0002-7360-429X
박혜선(Park, Hye Sun)
왕혜진(Wang, Hye Jin)
이상학(Lee, Sang Hak) ORCID logo https://orcid.org/0000-0002-4535-3745
이용호(Lee, Yong Ho) ORCID logo https://orcid.org/0000-0002-6219-4942
한유진(Han, Eu Gene)
Export
RIS (EndNote)
XLS (Excel)
XML
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/152628
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse